What is the current stock price of Gelesis Holdings, Inc. (GLS)?

As of the latest market data, Gelesis Holdings, Inc. (GLS) is trading at $0.16. The stock has seen a loss of 0.00% today.

Does Gelesis Holdings, Inc. (GLS) pay a dividend?

Based on current data, Gelesis Holdings, Inc. does not have a confirmed active dividend policy.

What is the market cap of Gelesis Holdings, Inc.?

The current market capitalization of Gelesis Holdings, Inc. (GLS) is approximately unavailable.

GLS

Gelesis Holdings, Inc.·Healthcare

0.16

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0152W H: $5.67

Company Profile

Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2022-01-14

Beta

0.99

Websitewww.gelesis.com↗